TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors — Stella

Recruiting

Back to Hepatocellular Carcinoma Non-resectable trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Tianjin Medical University Cancer Institute and Hospital, Tianjin

Key details

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Enrollment target

~40 participants

Started

October 2020

Primary completion

October 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 75 Years

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov